Tradercommunity Clickoptions Forum

[Newsagent]

PR inside: As GLP-1 Care Enters Its Second Act, T·TIME Launches Fixed-Rate Cash-Pay ...

(PR-inside.com) Compounded semaglutide and tirzepatide program keeps the same rate when the prescribed dose changes - a model built around the less glamorous part of the GLP-1 story: staying on treatment.

AUSTIN, TX / ACCESS Newswire / September 29, 2026 / The first act of the GLP-1 boom was about getting treatment. The second is increasingly about staying on it.

After years defined by shortages, waiting lists and extraordinary demand, obesity medicine is settling into a different kind of reality: refills, follow-up, dose adjustments and the economics of treatment that may extend well beyond the initial weight-loss phase.

T·TIME is launching its injectable program ..

https://reports.pr-inside.com/as-glp-1- ... 228457.htm
Copyright PR-Inside.com 2026